PE Hub

Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals

Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines.

Sacramento pharmaceutical manufacturer Nivagen acquired by private equity-backed PAI Pharma

PAI Pharma said the acquisition aligns with a growing national focus on reshoring pharmaceutical production, reducing ...

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market

"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...
Business Wire

Nivagen Pharmaceuticals Closes $16 Million Growth Equity Financing from Telegraph Hill Partners

SACRAMENTO, Calif.--(BUSINESS WIRE)--Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the closing of a $16 million equity financing round led by Telegraph Hill ...
Business Wire

Nivagen Pharmaceuticals Sells MedisourceRx Business Unit to Leading Health & Wellness Company

SACRAMENTO, Calif.--(BUSINESS WIRE)--Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the sale of its MedisourceRx business unit to the leading health and ...